4.4 Article

5-HT7 receptor activation: procognitive and antiamnesic effects

期刊

PSYCHOPHARMACOLOGY
卷 232, 期 3, 页码 595-603

出版社

SPRINGER
DOI: 10.1007/s00213-014-3693-0

关键词

Memory; Dysfunctional memory; Autoshaping; 5-HT7; Serotonin

资金

  1. CONACYT [80060]

向作者/读者索取更多资源

The serotonin (5-hydroxytryptamine (5-HT)) 5-HT7 receptor is localized in brain areas mediating memory; however, the role of this receptor on memory remains little explored. First, demonstrating the associative nature of Pavlovian/instrumental autoshaping (P/I-A) task, rats were exposed (three sessions) to CS-US (Pavlovian autoshaping), truly random control, free operant, and presentations of US or CS, and they were compared with rats trained-tested for one session to the P/I-A procedure. Also, effects of the 5-HT7 receptor agonist LP-211 administered intraperitoneally after training was determined on short- (1.5 h) and long-term memory 24 and 48 h) and on scopolamine-induced memory impairment and cAMP production. Autoshaping and its behavioral controls were studied. Other animals were subjected to an autoshaping training session and immediately afterwards were given (intraperitoneal) vehicle or LP-211 (0.1-10 mg/kg) and/or scopolamine (0.2 mg/kg) and tested for short-term memory (STM) and long-term memory (LTM); their brains were extracted for the cAMP ELISA immunoassay. P/I-A group produced the higher %CR. LP-211 did not affect STM; nonetheless, at 0.5 and 1.0 mg/kg, it improved LTM. The 5-HT7 receptor antagonist SB-269970 (SB; 10.0 mg/kg) alone had no effect; nevertheless, the LP-211 (1.0 mg/kg) LTM facilitation was reversed by SB. The scopolamine (0.2 mg/kg) induced-decrement in CR was accompanied by significant increased cAMP production. The scopolamine-induced decrement in CR and increments in cAMP were significantly attenuated by LP-211. Autoshaping is a reliable associative learning task whose consolidation is facilitated by the 5-HT7 receptor agonist LP-211.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Biochemistry & Molecular Biology

The Need To Improve Reporting of the Pharmacological Action of New Molecules

Clinton E. Canal, Marcello Leopoldo

Summary: The molecular characterization of bioactive molecules, such as small molecules targeting G-protein-coupled receptors, is becoming more complex, which affects the meanings of terms like agonist, antagonist, and selective. In the absence of detailed definitions and scientific consensus, these terms can cause confusion in the literature. We discuss this issue and offer straightforward solutions.

ACS CHEMICAL NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

In Vitro and In Silico Analysis of the Residence Time of Serotonin 5-HT7 Receptor Ligands with Arylpiperazine Structure: A Structure- Kinetics Relationship Study

Eduardo Penna, Mauro Niso, Sabina Podlewska, Floriana Volpicelli, Marianna Crispino, Carla Perrone-Capano, Andrzej J. Bojarski, Enza Lacivita, Marcello Leopoldo

Summary: The kinetics of drug-target interaction has been a topic of increasing interest in the field of pharmacology. Previous studies have shown the importance of the lipophilicity of a molecule in this process, but there has been limited research on the 5-HT7 receptor (5-HT7R), a GPCR involved in neurodevelopmental and neuropsychiatric disorders. In this study, the researchers explored the structure-kinetics relationships of a specific class of ligands for the 5-HT7R and found that the position of polar groups within the molecule, rather than overall lipophilicity, influenced the interaction kinetics. Additionally, molecular docking and dynamics simulations were used to gain further insights into the relationship between structure and kinetics.

ACS CHEMICAL NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

Design and Synthesis of Arylpiperazine Serotonergic/Dopaminergic Ligands with Neuroprotective Properties

Margherita Mastromarino, Mauro Niso, Carmen Abate, Ewgenij Proschak, Mariam Dubiel, Holger Stark, Marian Castro, Enza Lacivita, Marcello Leopoldo

Summary: Long-chain arylpiperazine scaffold is a versatile template for designing CNS drugs targeting serotonin and dopamine receptors. This study synthesized and evaluated ten new arylpiperazine derivatives with affinity profiles at serotonin and dopamine receptors, aiming to treat ASD or psychosis. The new compounds incorporated antioxidant fragments to counteract oxidative stress. Compound 12a showed an affinity profile compatible with antipsychotic activity, while compound 9b had an affinity profile consistent with ASD studies. Both compounds also had antioxidant properties.

MOLECULES (2022)

Article Chemistry, Medicinal

Behavioral, Anti-Inflammatory, and Neuroprotective Effects of a Novel FPR2 Agonist in Two Mouse Models of Autism

Claudia Cristiano, Floriana Volpicelli, Marianna Crispino, Enza Lacivita, Roberto Russo, Marcello Leopoldo, Antonio Calignano, Carla Perrone-Capano

Summary: Autism spectrum disorders (ASD) are a group of neurodevelopmental conditions characterized by social deficits, repetitive behaviors, and altered inflammatory responses. This study found that ASD children have decreased levels of lipoxin A4 (LXA4), a mediator involved in inflammation resolution. Activation of the receptor FPR2 by a compound called MR-39 had positive effects on inflammation markers, LXA4 expression, and social behavior in validated animal models of ASD. These findings suggest that FPR2 could be a potential target for therapeutic approaches in ASD.

PHARMACEUTICALS (2022)

Article Chemistry, Medicinal

Design, Synthesis, and Characterization of a Novel Fluoroprobe for Live Human Islet Cell Imaging of Serotonin 5-HT1A Receptor

Robert W. Garvey, Enza Lacivita, Mauro Niso, Beata Duszynska, Paul E. Harris, Marcello Leopoldo

Summary: This study reports the design, synthesis, and characterization of two novel fluorescent probes for the 5-HT1A receptor. One of the probes has the ability to selectively label the 5-HT1A receptor in pancreatic islet cells and shows useful properties for further characterization of this receptor's role.

CHEMMEDCHEM (2022)

Article Chemistry, Medicinal

Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2)Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders

Margherita Mastromarino, Maria Favia, Igor A. Schepetkin, Lylia N. Kirpotina, Ewa Trojan, Mauro Niso, Antonio Carrieri, Monika Leskiewicz, Magdalena Regulska, Massimiliano Darida, Francesco Rossignolo, Stefano Fontana, Mark T. Quinn, Agnieszka Basta-Kaim, Marcello Leopoldo, Enza Lacivita

Summary: Formyl peptide receptor 2 (FPR2) agonists, including the newly identified ureidopropanamide derivatives, show promising potential in resolving inflammation and treating neurodegenerative disorders with underlying chronic neuroinflammation. Computational studies provide insights into the interactions between these compounds and FPR2. In vitro and in vivo experiments demonstrate the anti-inflammatory effects and improved mitochondrial function of selected compounds.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Multidisciplinary

LC-MS/MS Analysis on Infusion Bags and Filled Syringes of Decitabine: New Data on Physicochemical Stability of an Unstable Molecule

Mariarita Laforgia, Loredana Amodio, Santina Colangiulo, Valentina Ungaro, Letizia Gatti, Gianpiero Lucarelli, Marcello Leopoldo, Patrizia Nardulli, Nicola A. Colabufo

Summary: Many anticancer drugs have low physicochemical stability after dilution, which can lead to delays in drug administration for cancer patients. Independent analytical studies can help reduce the public health costs caused by discarded drugs. Decitabine is more stable than previously reported.

ACS OMEGA (2022)

Editorial Material Neurosciences

The Formyl Peptide Receptor 2 as a Target for Promotion of Resolution of Inflammation

Ewa Trojan, Monika Leskiewicz, Enza Lacivita, Marcello Leopoldo, Agnieszka Basta-Kaim

CURRENT NEUROPHARMACOLOGY (2023)

Article Biochemistry & Molecular Biology

Stimulation of Formyl Peptide Receptor-2 by the New Agonist CMC23 Protects against Endotoxin-Induced Neuroinflammatory Response: A Study in Organotypic Hippocampal Cultures

Kinga Tylek, Ewa Trojan, Monika Leskiewicz, Fabio Francavilla, Enza Lacivita, Marcello Leopoldo, Agnieszka Basta-Kaim

Summary: A substantial body of evidence shows a link between dysfunctional acute inflammation resolution and the development of chronic inflammation. The importance of formyl peptide receptor 2 (FPR2) has been highlighted in this context. The activity of FPR2 is regulated by a range of endogenous ligands, including specialized pro-resolving mediators (SPMs) and synthetic ligands. A new potent FPR2 agonist, compound CMC23, has been found to have protective and anti-inflammatory effects.

ACS CHEMICAL NEUROSCIENCE (2023)

Article Cell Biology

Microglia Depletion Attenuates the Pro-Resolving Activity of the Formyl Peptide Receptor 2 Agonist AMS21 Related to Inhibition of Inflammasome NLRP3 Signalling Pathway: A Study of Organotypic Hippocampal Cultures

Kinga Tylek, Ewa Trojan, Monika Leskiewicz, Imane Ghafir El Idrissi, Enza Lacivita, Marcello Leopoldo, Agnieszka Basta-Kaim

Summary: Microglial cells play a significant role in maintaining homeostasis and resolving inflammation. The study found that a new ureidopropanamide agonist, AMS21, has protective and anti-inflammatory effects in LPS-stimulated hippocampal cells. These effects are mediated through the FPR2 receptor specifically located on microglial cells.
Article Biochemistry & Molecular Biology

Metformin Prevents NDEA-Induced Memory Impairments Associated with Attenuating Beta-Amyloid, Tumor Necrosis Factor-Alpha, and Interleukin-6 Levels in the Hippocampus of Rats

Teresa Ponce-Lopez, Jose Antonio Gonzalez Alvarez Tostado, Fernando Dias, Keren Happuck Montiel Maltez

Summary: N-nitrosodiethylamine (NDEA) is a potential carcinogen that causes liver tumors, chronic inflammation, diabetes, cognitive problems, and Alzheimer's disease-like symptoms in animals. Metformin may protect against memory issues and brain inflammation triggered by NDEA.

BIOMOLECULES (2023)

暂无数据